ExSight Ventures
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
- USA Canada
Investment stages
- Seed
- Series A
Industries
- Biotechnology
- Health Tech
- AI
About
ExSight Ventures is a mission-focused venture capital firm investing in early-stage ophthalmic solutions, led by retinal surgeons to bridge the funding gap in life sciences.
ExSight Ventures is a mission-focused venture capital firm investing in early-stage ophthalmic solutions, led by retinal surgeons to bridge the funding gap in life sciences.
Investment Thesis
ExSight Ventures invests in earlystage ophthalmic diagnostic and treatment solutions to address the lack of earlystage funding available to life science companies, relying on deep domain expertise in ophthalmology.
ExSight Ventures Contacts Information
Primary contact
Portfolio
ELIOS Vision
Re-Vana Therapeutics
Horizon Surgical Systems
DTx Pharma (acquired by Novartis)
Trefoil Therapeutics
Qura
Envision Diagnostics
2C Tech Corporation
ONL Therapeutics
RetroSense Therapeutics (acquired by Allergan)
LensGen
Valitor Bio
Novai.